Structures of mouse and human GITR-GITRL complexes reveal unique TNF superfamily interactions

Feng Wang1, Bryant Chau1, Sean M West1

  • 1Discovery Biotherapeutics, Bristol Myers Squibb, Redwood City, CA, USA.

Nature Communications
|March 3, 2021
PubMed

Insights

Glucocorticoid-induced tumor necrosis factor receptor (GITR) and its ligand (GITRL) structures reveal how they interact on cell surfaces. These findings are crucial for developing new immunotherapies targeting cancer.

Area of Science:

  • Immunology
  • Structural Biology
  • Biochemistry

Background:

  • Glucocorticoid-induced tumor necrosis factor receptor (GITR) and GITR ligand (GITRL) are key regulators of immune responses within the tumor necrosis superfamily.
  • GITR is a therapeutic target for modulating T cell activity and promoting anti-tumor immunity.
  • Understanding the structural basis of GITR-GITRL interaction is essential for designing effective immunotherapies.

Purpose of the Study:

  • To determine the structures of human and mouse GITR receptors bound to their cognate ligands.
  • To elucidate the molecular mechanisms underlying GITR-GITRL interactions and higher-order complex formation.
  • To investigate the functional consequences of altering the GITR-GITRL interface on cell signaling.

Main Methods:

  • X-ray crystallography to determine the structures of GITR-GITRL complexes.
  • In vitro ligand binding assays to assess the impact of interface mutations on binding affinity.
  • Cell imaging experiments using fluorescently labeled ligands to visualize membrane complex formation.

Main Results:

  • The structures reveal conserved receptor-ligand and receptor-receptor interfaces between human and mouse GITR-GITRL complexes.
  • Human GITR-GITRL can form hexameric membrane networks, while murine GITR-GITRL forms linear chains.
  • Mutations at the human GITR receptor-receptor interface decrease cell signaling and higher-order membrane structure formation.

Conclusions:

  • The unique C-terminal receptor-receptor interface enables distinct higher-order structures of GITR-GITRL complexes on cell membranes.
  • These structural insights provide a foundation for developing targeted therapies that modulate GITR signaling for cancer treatment.
  • Understanding the species-specific assembly of GITR-GITRL complexes is critical for preclinical translation of GITR-based immunotherapies.